Covid vaccine: India begins testing indigenous candidate at PGIMS, Rohtak
Updated on Jul 18, 2020 08:15 am IST
Human trials of a Covid vaccine candidate, developed in India, have begun. Trials of the drug named Covaxin are being conducted at PGIMS, Rohtak. Bharat Biotech and ICMR's National Institute of Virology, Pune developed Covaxin. The other trial vaccine developed in India is Zydus Cadila's ZyCov-D. The trials are being conducted as India's total case tally has crossed 10 lakh-mark.
{{^htLoading}} {{/htLoading}}